您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

蘇子佩醫師

一般核醫學、心臟核醫學、正子掃描、核素治療
  • 國語,英語,閩南語
  • 助理教授
醫師資歷
  • 現職
    • 核子醫學科學術組助理教授級主治醫師
  • 學歷
    • 台灣大學醫學系畢業
  • 經歷
    • 基隆長庚紀念醫院核子醫學科主治醫師
    • 板橋亞東紀念醫院內科住院醫師
  • 學會與認證
    • 台灣核醫學會
    • 美國核醫心臟學會
  • 論文及期刊發表
    • Evaluating the Efficacy and Safety of Pluvicto in Chemotherapy-Ineligible Nonagenarians: A Descriptive Case Series.
      Cureus 2025; Feb;17(2): e79119. doi:10.7759/cureus.79119.
      Charron J, Maupin K, Su C, et al.
    • Artificial intelligence-enhanced electrocardiography improves the detection of coronary artery disease.
      Comput Struct Biotechnol J. 2025 Jan; 27:278-286. doi: 0.1016/j.csbj.2024.12.032.
      Yeh CH, Tsai TH, Chen CH, Chou YJ, Mao CT, Su TP, Yang NI, Lai CC, Chen CT, Sytwu HK, Tsai TF.
    • Potential false-positive Meckel scan due to displaced kidney caused by recurrent retroperitoneal teratoma.
      Clin Nucl Med. 2014 Oct;39(10):e433-5. doi: 10.1097/RLU.0000000000000264.
      Su TP, Cheng NM, Chuang HC, Chen CC, Lin C.
    • TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
      Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2155-2165. doi: 10.1007/s00259-016-3433-2.
      Ho KC, Fang YD, Chung HW, Liu YC, Chang JW, Hou MM, Yang CT, Cheng NM, Su TP, Yen TC.
    • Detecting Triple-Vessel Disease with Cadmium Zinc Telluride-Based Single-Photon Emission Computed Tomography Using the Intensity Signal-to-Noise Ratio between Rest and Stress Studies.
      Contrast Media Mol Imaging. 2017 Oct 15;2017:4945680. doi: 10.1155/2017/4945680.
      Fang YD, Su TP, Chang CJ, Ho KC, Su M, Yen TC.
    • Comparison of Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Posttherapy Evaluation in Patients with Advanced Cervical Cancer Receiving Definitive Concurrent Chemoradiotherapy.
      Eur J Nucl Med Mol Imaging. 2018 May;45(5):727-734. doi: 10.1007/s00259-017-3884-0.
      Su TP, Lin G, Huang YT, Liu FY, Wang CC, Chao A, Chou HH, Yen TC, Lai CH.
    • Roles of posttherapy 18F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy.
      Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1197-1204. doi: 10.1007/s00259-018-3957-8.
      Liu FY, Su TP, Wang CC, Chao A, Chou HH, Chang YC, Yen TC, Lai CH.
    • Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer.
      BMC Cancer. 2021 Aug 10;21(1):908. doi: 10.1186/s12885-021-08649-z.
      Su TP, Huang JS, Chang PH, Lui KW, Hsieh JCH, Ng SH, Chan SC.
    • Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases.
      Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):467-477. doi: 10.1007/s00259-018-4210-1.
      Ho KC, Toh CH, Li SH, Liu CY, Yang CT, Lu YJ, Su TP, Wang CW, Yen TC.
    • Prognostic Value and Clinical Impact of Pretreatment FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma.
      Clin Nucl Med. 2019 Feb;44(2):e68-e75. doi: 10.1097/RLU.0000000000002371.
      Su TP, Ho KC, Wang CW, Lin CY, Liu CY, Yang CT, Yen TC.